Page last updated: 2024-10-25

deferiprone and Tachycardia

deferiprone has been researched along with Tachycardia in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taher, A1
Sheikh-Taha, M1
Koussa, S1
Inati, A1
Neeman, R1
Mourad, F1

Trials

1 trial available for deferiprone and Tachycardia

ArticleYear
Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
    European journal of haematology, 2001, Volume: 67, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Deferiprone; De

2001